Early Detection Leads to Better Outcomes
Lung cancer takes more lives each year than breast, colon, and prostate cancers combined. Here in Oklahoma, the numbers are even more concerning. According to the American Lung Association’s 2023 “State of Lung Cancer” report, our state has one of the lowest five-year survival rates in the country, with only 21% of people surviving five years after diagnosis, compared to the national average of nearly 27%.
One reason lung cancer survival rates are lower is that patients are often diagnosed after the cancer has already spread beyond the original tumor. This makes treatment more challenging. Catching lung cancer early makes a big difference. When found in its earliest stages, survival rates improve significantly. That’s why we’ve invested in advanced technology like Ion Robotic Bronchoscopy—to help shorten the time between finding a spot on the lung and getting a clear diagnosis, so treatment can begin as soon as possible.
Many lung cancer nodules—over 70%—are found in the outer areas of the lung, where tight spaces and narrow airways can make them hard to reach. Until now, doctors haven’t had a go-to tool for safely and precisely reaching these spots. That’s where Ion comes in. Ion is an innovative robotic-assisted technology that allows our doctors to perform minimally invasive biopsies in these hard-to-reach areas, which could play a key role in catching lung cancer earlier and improving outcomes.